RNF213 and major depressive disorder: As ECT has been demonstrated to have immunomodulatory properties [51–54] and to (partially) reverse the immunological irregularities found in MDD patients (or at least in a subgroup thereof) [55, 56], the immune system seems to serve as another link between the strong implication of RNF213’s DNAm and the clinical response to ECT.